Analystreport

Corvus Pharmaceuticals Inc (NASDAQ: CRVS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Corvus Pharmaceuticals, Inc.  (CRVS) 
Last corvus pharmaceuticals, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corvuspharma.com